CymitQuimica logo
Carbonic Anhydrase

Carbonic Anhydrase

Carbonic anhydrase is an enzyme that catalyzes the reversible conversion of carbon dioxide and water into bicarbonate and protons. This enzyme plays a crucial role in maintaining acid-base balance, respiration, and the transport of carbon dioxide in the blood. Inhibitors of carbonic anhydrase are used in the treatment of glaucoma, epilepsy, and altitude sickness, as well as in research on acid-base homeostasis and gas exchange. At CymitQuimica, we offer a range of high-quality carbonic anhydrase inhibitors and reagents to support your research in enzymology, respiratory physiology, and therapeutic development.

Found 221 products for "Carbonic Anhydrase".

products per page.
  • Acipimox

    CAS:
    Acipimox (K-9321), a niacin derivative, treats hyperlipidemia in type 2 diabetics.
    Formula:C6H6N2O3
    Purity:98.98% - 99.71%
    Color and Shape:Solid
    Molecular weight:154.1234
  • Benzthiazide

    CAS:
    Benzthiazide treats edema and hypertension by promoting diuresis and inhibiting kidney Na+/Cl- reuptake, but may reduce potassium and raise uric acid.
    Formula:C15H14ClN3O4S3
    Purity:98.48% - 99.79%
    Color and Shape:White Solid
    Molecular weight:431.937
  • Hydrochlorothiazide

    CAS:
    Hydrochlorothiazide (HCTZ) 是一种口服有效的噻嗪类的利尿药,可抑制转化 TGF-β/Smad 信号通路。它通过打开钙激活钾 (KCA) 通道发挥直接的血管松弛作用。它改善心脏功能,减少纤维化并具有降压作用。
    Formula:C7H8ClN3O4S2
    Purity:99.43% - 99.50%
    Color and Shape:White Solid
    Molecular weight:297.739
  • Methazolamide

    CAS:
    Methazolamide (CL 8490) is a carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
    Formula:C5H8N4O3S2
    Purity:99.31% - 99.77%
    Color and Shape:Solid
    Molecular weight:236.27
  • Actarit

    CAS:
    Actarit (4-acetylaminophenylacetic acid) is an anti-inflammatory drug.
    Formula:C10H11NO3
    Purity:99.64% - 99.74%
    Color and Shape:White Or Off-White Crystal Or Crystalline Solid
    Molecular weight:193.1992
  • Brinzolamide

    CAS:
    Brinzolamide (AL-4862) is a Carbonic Anhydrase Inhibitor. The mechanism of action of brinzolamide is as a Carbonic Anhydrase Inhibitor.
    Formula:C12H21N3O5S3
    Purity:99.84% - >99.99%
    Color and Shape:Solid
    Molecular weight:383.51
  • Girentuximab

    CAS:
    Girentuximab (G250) is an anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anti-cancer activity for the study of uroepithelial carcinoma PET (ZiPUP).
    Color and Shape:Transparent Liquid
    Molecular weight:145.55 kDa (Predicted)
  • Methocarbamol

    CAS:
    Methocarbamol (AHR 85) is a centrally acting muscle relaxant whose mode of action has not been established.
    Formula:C11H15NO5
    Purity:99.96%
    Color and Shape:White Solid
    Molecular weight:241.2405
  • Zonisamide

    CAS:
    Zonisamide (AD 810), a sulfonamide anticonvulsant, is approved for use as an adjunctive treatment in adults with partial-onset seizures.
    Formula:C8H8N2O3S
    Purity:99.05% - 99.9%
    Color and Shape:Solid
    Molecular weight:212.226
  • Topiramate

    CAS:
    Topiramate (RWJ 17021) is a unique antiseizure medication that is used in the treatment of partial and generalized seizures.
    Formula:C12H21NO8S
    Purity:99.79% - 99.92%
    Color and Shape:Solid
    Molecular weight:339.36
  • CAIX Inhibitor S4

    CAS:
    CAIX Inhibitor S4 (S4) is an effective inhibitor of carbonic anhydrase IX/XII with a Ki of 7 nM and 2 nM, respectively.
    Formula:C15H17N3O4S
    Purity:99.07%
    Color and Shape:Solid
    Molecular weight:335.38
  • Tioxolone

    CAS:
    Tioxolone is a metalloenzyme carbonic anhydrase I inhibitor.
    Formula:C7H4O3S
    Purity:97.79%
    Color and Shape:White Solid
    Molecular weight:168.17
  • pNNP

    CAS:
    pNNP is a substrate for PP2C assays and inhibits β-carbonic anhydrase, α-carbonate dehydrogenase, and H. pylori.
    Formula:C6H6NO6P
    Purity:99.82%
    Color and Shape:White Solid
    Molecular weight:219.09
  • hCA-IN-1


    hCA-IN-1 (Compound 5u) is an hCA inhibitor with Ki values of 159.2 nM for hCA I, 4.8 nM for hCA II, 15.5 nM for CAIX, and 2 nM for CAXII. It demonstrates broad-spectrum anticancer activity against melanoma, breast cancer, and colon cancer cells. ADME predictions indicate that hCA-IN-1 has good solubility and oral bioavailability. This compound is useful in tumor research.
  • Carbonic anhydrase-IN-37


    Carbonic anhydrase-IN-37 (compound 9a) is a potent and orally active inhibitor of carbonic anhydrase (CA), exhibiting Ki values of 9.7 nM for hCA VA and 1.0 nM for hCA VB. It demonstrates anti-hyperalgesic and anti-allodynic properties in a mouse model of paclitaxel-induced neuropathic pain, making it useful for neuropathic pain research.
  • hCAIX-IN-22


    hCAIX-IN-22 is a highly selective inhibitor of the human carbonic anhydrase (hCA) XII subtype, exhibiting anticancer activity with an inhibition constant (Ki) of 9.7 nM.
  • DOTA-XYIMSR-01

    CAS:
    DOTA-XYIMSR-01 is a molecular probe targeting CAIX, capable of being labeled with 177Lu for the treatment and localization of malignant gliomas. The uptake of [177Lu]Lu-XYIMSR-01 in U87MG tumors is 6.19% injected dose per gram (% ID/g), with a tumor-to-muscle uptake ratio of 20.14. In an orthotopic glioma model, co-administration with temozolomide significantly enhances survival rates and inhibits tumor growth in mice. DOTA-XYIMSR-01 shows potential for research in the field of cancer treatment.
    Formula:C61H88N16O22S2
    Color and Shape:Solid
    Molecular weight:1461.57
  • IPM-N001


    IPM-N001 is a ligand for carbonic anhydrase IX (CAIX) with a Kd value of less than 0.0337 nM for hCAIX. When radiolabeled with 68Ga, it serves as a CAIX-targeting radionuclide tracer. [68Ga]Ga-IPM-N001 demonstrates excellent tumor uptake and significantly enhances the tumor-to-background ratio in PET/CT imaging studies using OS-RC-2 tumor-bearing mice. IPM-N001 is applicable for research on clear cell renal cell carcinoma.
  • CA IX-IN-5


    CAIX-IN-5 (compound 9) is an inhibitor of human carbonic anhydrase IX (hCA IX), exhibiting a Ki of 7.4 nM for hCA IX and a Ki of 25.0 nM for hCA II. It effectively inhibits the isoenzymes hCA IX and hCA II, showing higher selectivity for hCA IX than hCA II. CAIX-IN-5 is used in research related to breast cancer, colorectal cancer, glioblastoma, lung cancer, head and neck cancer, and cervical cancer.
  • CAIX/CAXII-IN-2


    CAIX/CAXII-IN-2 (compound 23) is a CAIX/CAXII inhibitor, exhibiting Ki values of 8.9 nM for CAIX and 5.3 nM for CAXII. It is applicable in cancer research.
    Formula:C16H14N4O2S
    Molecular weight:326.08375